Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

In Silico Modeling of Minimal Effective Insulin Doses Using the UVA/PADOVA Type 1 Diabetes Simulator.

Campos-Náñez E, Layne JE, Zisser HC.

J Diabetes Sci Technol. 2018 Mar;12(2):376-380. doi: 10.1177/1932296817735341. Epub 2017 Sep 27.

2.

Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.

Dassau E, Renard E, Place J, Farret A, Pelletier MJ, Lee J, Huyett LM, Chakrabarty A, Doyle FJ 3rd, Zisser HC.

Diabetes Obes Metab. 2017 Dec;19(12):1698-1705. doi: 10.1111/dom.12999. Epub 2017 Jul 6.

3.

Response to Comment on Pinsker et al. Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas. Diabetes Care 2016;39:1135-1142.

Pinsker JE, Lee JB, Dassau E, Seborg DE, Bradley PK, Gondhalekar R, Bevier WC, Huyett L, Zisser HC, Doyle FJ 3rd.

Diabetes Care. 2017 Jan;40(1):e4-e5. doi: 10.2337/dci16-0038. No abstract available.

4.

Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas.

Pinsker JE, Lee JB, Dassau E, Seborg DE, Bradley PK, Gondhalekar R, Bevier WC, Huyett L, Zisser HC, Doyle FJ 3rd.

Diabetes Care. 2016 Jul;39(7):1135-42. doi: 10.2337/dc15-2344. Epub 2016 Jun 11.

5.

Preliminary Evaluation of a Long-Term Intraperitoneal Glucose Sensor With Flushing Mechanism.

Huyett LM, Mittal R, Zisser HC, Luxon ES, Yee A, Dassau E, Doyle FJ 3rd, Burnett DR.

J Diabetes Sci Technol. 2016 Aug 22;10(5):1192-4. doi: 10.1177/1932296816640542. Print 2016 Sep. No abstract available.

6.

Is Psychological Stress a Factor for Incorporation Into Future Closed-Loop Systems?

Gonder-Frederick LA, Grabman JH, Kovatchev B, Brown SA, Patek S, Basu A, Pinsker JE, Kudva YC, Wakeman CA, Dassau E, Cobelli C, Zisser HC, Doyle FJ 3rd.

J Diabetes Sci Technol. 2016 May 3;10(3):640-6. doi: 10.1177/1932296816635199. Print 2016 May.

7.

Design and Evaluation of a Robust PID Controller for a Fully Implantable Artificial Pancreas.

Huyett LM, Dassau E, Zisser HC, Doyle FJ 3rd.

Ind Eng Chem Res. 2015 Oct 28;54(42):10311-10321. Epub 2015 Jun 9.

8.

Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial.

Dassau E, Brown SA, Basu A, Pinsker JE, Kudva YC, Gondhalekar R, Patek S, Lv D, Schiavon M, Lee JB, Dalla Man C, Hinshaw L, Castorino K, Mallad A, Dadlani V, McCrady-Spitzer SK, McElwee-Malloy M, Wakeman CA, Bevier WC, Bradley PK, Kovatchev B, Cobelli C, Zisser HC, Doyle FJ 3rd.

J Clin Endocrinol Metab. 2015 Oct;100(10):3878-86. doi: 10.1210/jc.2015-2081. Epub 2015 Jul 23.

9.

Response to comment on Doyle et al. Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care 2014;37:1191-1197.

Doyle FJ 3rd, Huyett LM, Lee JB, Zisser HC, Kerr D, Dassau E.

Diabetes Care. 2014 Oct;37(10):e228. doi: 10.2337/dc14-1693. No abstract available.

PMID:
25249687
10.

Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas.

Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Anderson SM, Brown SA, Chernavvsky DR, Breton MD, Mize LB, Farret A, Place J, Bruttomesso D, Del Favero S, Boscari F, Galasso S, Avogaro A, Magni L, Di Palma F, Toffanin C, Messori M, Dassau E, Doyle FJ 3rd.

Diabetes Care. 2014 Jul;37(7):1789-96. doi: 10.2337/dc13-2076. Epub 2014 Jun 14.

11.

Artificial pancreas (AP) clinical trial participants' acceptance of future AP technology.

Bevier WC, Fuller SM, Fuller RP, Rubin RR, Dassau E, Doyle FJ 3rd, Jovanovič L, Zisser HC.

Diabetes Technol Ther. 2014 Sep;16(9):590-5. doi: 10.1089/dia.2013.0365. Epub 2014 May 8.

12.

Closed-loop artificial pancreas systems: engineering the algorithms.

Doyle FJ 3rd, Huyett LM, Lee JB, Zisser HC, Dassau E.

Diabetes Care. 2014;37(5):1191-7. doi: 10.2337/dc13-2108.

13.

Glucose sensing in the peritoneal space offers faster kinetics than sensing in the subcutaneous space.

Burnett DR, Huyett LM, Zisser HC, Doyle FJ 3rd, Mensh BD.

Diabetes. 2014 Jul;63(7):2498-505. doi: 10.2337/db13-1649. Epub 2014 Mar 12.

14.

Clinical evaluation of an automated artificial pancreas using zone-model predictive control and health monitoring system.

Harvey RA, Dassau E, Bevier WC, Seborg DE, Jovanovič L, Doyle FJ 3rd, Zisser HC.

Diabetes Technol Ther. 2014 Jun;16(6):348-57. doi: 10.1089/dia.2013.0231. Epub 2014 Jan 28.

15.

Periodic-zone model predictive control for diurnal closed-loop operation of an artificial pancreas.

Gondhalekar R, Dassau E, Zisser HC, Doyle FJ 3rd.

J Diabetes Sci Technol. 2013 Nov 1;7(6):1446-60.

16.

Artificial pancreas goes outpatient: a new diabetes ecosystem.

Renard E, Cobelli C, Zisser HC, Kovatchev BP.

J Diabetes Sci Technol. 2013 Nov 1;7(6):1411-5. No abstract available.

17.

Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas.

Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Anderson SM, Brown SA, Chernavvsky DR, Breton MD, Farret A, Pelletier MJ, Place J, Bruttomesso D, Del Favero S, Visentin R, Filippi A, Scotton R, Avogaro A, Doyle FJ 3rd.

Diabetes Care. 2013 Jul;36(7):1851-8. doi: 10.2337/dc12-1965.

18.

Technology to inform insulin dose adjustments: its time is near.

Zisser HC.

Diabetes Technol Ther. 2012 Aug;14(8):649-50. doi: 10.1089/dia.2012.0162. No abstract available.

PMID:
22853718
19.

Predicting subcutaneous glucose concentration using a latent-variable-based statistical method for type 1 diabetes mellitus.

Zhao C, Dassau E, Jovanovič L, Zisser HC, Doyle FJ 3rd, Seborg DE.

J Diabetes Sci Technol. 2012 May 1;6(3):617-33.

20.

Clinically relevant hypoglycemia prediction metrics for event mitigation.

Harvey RA, Dassau E, Zisser HC, Bevier W, Seborg DE, Jovanovič L, Doyle FJ 3rd.

Diabetes Technol Ther. 2012 Aug;14(8):719-27. doi: 10.1089/dia.2011.0198. Epub 2012 Jun 12.

21.

Control-relevant models for glucose control using a priori patient characteristics.

van Heusden K, Dassau E, Zisser HC, Seborg DE, Doyle FJ 3rd.

IEEE Trans Biomed Eng. 2012 Jul;59(7):1839-49. doi: 10.1109/TBME.2011.2176939. Epub 2011 Nov 22.

PMID:
22127988
22.

Accuracy performance of the Medtronic NexSensor™ for 6 days in an inpatient setting using abdomen and buttocks insertion sites.

Peoples T, Bailey T, Ronald B, Zisser HC, Janowski B, Huang S, Talbot C, Yang Q.

J Diabetes Sci Technol. 2011 Mar 1;5(2):358-64.

23.

Fetal risk assessment in pregnancies complicated by diabetes mellitus.

Zisser HC, Biersmith MA, Jovanovič LB, Yogev Y, Hod M, Kovatchev BP.

J Diabetes Sci Technol. 2010 Nov 1;4(6):1368-73.

24.

Modeling the effects of subcutaneous insulin administration and carbohydrate consumption on blood glucose.

Percival MW, Bevier WC, Wang Y, Dassau E, Zisser HC, Jovanovič L, Doyle FJ 3rd.

J Diabetes Sci Technol. 2010 Sep 1;4(5):1214-28.

25.

The OmniPod Insulin Management System: the latest innovation in insulin pump therapy.

Zisser HC.

Diabetes Ther. 2010 Aug;1(1):10-24. doi: 10.1007/s13300-010-0004-6. Epub 2010 Sep 13.

26.

Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.

Grosman B, Dassau E, Zisser HC, Jovanovic L, Doyle FJ 3rd.

J Diabetes Sci Technol. 2010 Jul 1;4(4):961-75.

27.

Siphon effects on continuous subcutaneous insulin infusion pump delivery performance.

Zisser HC, Bevier W, Dassau E, Jovanovic L.

J Diabetes Sci Technol. 2010 Jan 1;4(1):98-103.

28.

Experimental evaluation of a recursive model identification technique for type 1 diabetes.

Finan DA, Doyle FJ 3rd, Palerm CC, Bevier WC, Zisser HC, Jovanovic L, Seborg DE.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1192-202.

29.

Accuracy of the SEVEN continuous glucose monitoring system: comparison with frequently sampled venous glucose measurements.

Zisser HC, Bailey TS, Schwartz S, Ratner RE, Wise J.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1146-54.

30.

A novel adaptive basal therapy based on the value and rate of change of blood glucose.

Wang Y, Percival MW, Dassau E, Zisser HC, Jovanovic L, Doyle FJ 3rd.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1099-108.

31.

Progress in development of an artificial pancreas.

Klonoff DC, Cobelli C, Kovatchev B, Zisser HC.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1002-4.

32.
33.

Continuous glucose monitoring: is it helpful in pregnancy?

Byrne EZ, Zisser HC, Jovanovic L.

Curr Diabetes Rev. 2008 Aug;4(3):223-6. Review.

PMID:
18690904
34.

Use of continuous glucose monitoring to estimate insulin requirements in patients with type 1 diabetes mellitus during a short course of prednisone.

Bevier WC, Zisser HC, Jovanovic L, Finan DA, Palerm CC, Seborg DE, Doyle FJ 3rd.

J Diabetes Sci Technol. 2008 Jul;2(4):578-83.

35.

Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus.

Zisser HC, Bevier WC, Jovanovic L.

Diabetes Technol Ther. 2007 Dec;9(6):509-15.

PMID:
18034605
36.

Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study.

Bailey TS, Zisser HC, Garg SK.

Diabetes Technol Ther. 2007 Jun;9(3):203-10.

PMID:
17561790
37.

Screening for and treatment of polycystic ovary syndrome in teenagers.

Salmi DJ, Zisser HC, Jovanovic L.

Exp Biol Med (Maywood). 2004 May;229(5):369-77. Review.

PMID:
15096648
38.

Photographic simulation of image quality through bifocal intraocular lenses.

Zisser HC, Guyton DL.

Am J Ophthalmol. 1989 Sep 15;108(3):324-6. No abstract available.

PMID:
2774041

Supplemental Content

Loading ...
Support Center